McKesson Corporation ( (MCK) ) has released its Q2 earnings. Here is a breakdown of the information McKesson Corporation presented to its ...
Analyst Charles Rhyee from TD Cowen maintained a Buy rating on McKesson (MCK – Research Report) and decreased the price target to $651.00 ...
Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that ...